vs
Side-by-side financial comparison of Evogene Ltd. (EVGN) and QIAGEN N.V. (QGEN), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technolo...
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located ...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q2 25 | $3.2M | — | ||
| Q2 24 | $2.3M | — |
| Q2 25 | $-7.7M | — | ||
| Q2 24 | $-9.8M | — |
| Q2 25 | 48.8% | — | ||
| Q2 24 | 71.8% | — |
| Q2 25 | -189.0% | — | ||
| Q2 24 | -409.9% | — |
| Q2 25 | -237.7% | — | ||
| Q2 24 | -428.5% | — |
| Q2 25 | — | — | ||
| Q2 24 | $-1.82 | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
